Gut Microbiota in Human Systemic Lupus Erythematosus and a Mouse Model of Lupus
- 15 February 2018
- journal article
- research article
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 84 (4)
Abstract
Gut microbiota dysbiosis has been observed in a number of autoimmune diseases. However, the role of the gut microbiota in systemic lupus erythematosus (SLE), a prototypical autoimmune disease characterized by persistent inflammation in multiple organs of the body, remains elusive. Here we report the dynamics of the gut microbiota in a murine lupus model, NZB/W F1, as well as intestinal dysbiosis in a small group of SLE patients with active disease. The composition of the gut microbiota changed markedly before and after the onset of lupus disease in NZB/W F1 mice, with greater diversity and increased representation of several bacterial species as lupus progressed from the predisease stage to the diseased stage. However, we did not control for age and the cage effect. Using dexamethasone as an intervention to treat SLE-like signs, we also found that a greater abundance of a group of lactobacilli (for which a species assignment could not be made) in the gut microbiota might be correlated with more severe disease in NZB/W F1 mice. Results of the human study suggest that, compared to control subjects without immune-mediated diseases, SLE patients with active lupus disease possessed an altered gut microbiota that differed in several particular bacterial species (within the genera Odoribacter and Blautia and an unnamed genus in the family Rikenellaceae ) and was less diverse, with increased representation of Gram-negative bacteria. The Firmicutes / Bacteroidetes ratios did not differ between the SLE microbiota and the non-SLE microbiota in our human cohort. IMPORTANCE SLE is a complex autoimmune disease with no known cure. Dysbiosis of the gut microbiota has been reported for both mice and humans with SLE. In this emerging field, however, more studies are required to delineate the roles of the gut microbiota in different lupus-prone mouse models and people with diverse manifestations of SLE. Here, we report changes in the gut microbiota in NZB/W F1 lupus-prone mice and a group of SLE patients with active disease.Keywords
Funding Information
- NIAMS (1R15AR067418)
- NIAID (5R03AI117597)
This publication has 32 references indexed in Scilit:
- Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patientsScientific Reports, 2016
- Burden of Serious Infections in Adults With Systemic Lupus Erythematosus: A National Population‐Based Study, 1996–2011Arthritis Care & Research, 2015
- UPARSE: highly accurate OTU sequences from microbial amplicon readsNature Methods, 2013
- Systemic Lupus ErythematosusNew England Journal of Medicine, 2011
- An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaeaThe ISME Journal, 2011
- The role of bacteria and pattern-recognition receptors in Crohn's diseaseNature Reviews Gastroenterology & Hepatology, 2011
- QIIME allows analysis of high-throughput community sequencing dataNature Methods, 2010
- Plasma IL-17A Is Increased in New-Onset SLE Patients and Associated with Disease ActivityJournal of Clinical Immunology, 2010
- Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosusNature Immunology, 2009
- The treatment of systemic lupus erythematosus (SLE) in NZB/W F1 hybrid mice; studies with recombinant murine DNase and with dexamethasoneClinical and Experimental Immunology, 1996